Pulike Biological Engineering, Inc. - MacroPolo Pulike Biological Engineering, Inc. - MacroPolo
Healthcare

As the world’s second-largest healthcare market, China spends about $575 billion a year on the sector, roughly equivalent to Sweden’s GDP. But because of China’s large population, that translates into only $420 in per capita healthcare spending, just 4% of what an average American spends. This healthcare supply shortage is exacerbated by rising demand from wealthier Chinese who seek quality care, better insurance, and diverse services.

On the regulatory side, the Chinese government continues to reform the healthcare sector by allowing doctors to work

outside the public hospital system, encouraging the privatization of hospitals, and expanding public healthcare insurance to cover private hospitals.

The significant mismatch between supply and demand, coupled with policy changes to support the sector, have incentivized private investment to flock into areas ranging from advanced pharmaceuticals and medical devices to primary care clinics, elderly care, and insurance products.

Pulike Biological Engineering, Inc.

Pulike Biological Engineering, Inc.

Company Overview

COMPANY DESCRIPTION

Pulike Biological Engineering focuses producing and distributing vaccines and chemicals for animals. The firm’s main products include avian influenza and hog vaccines. It has also set up an asset management company with three other firms to focus on investment opportunities in agriculture.

CHAIRPERSON

Zhang Xuke

HEADQUARTERS

Luoyang, Henan

PHONE

(379) 6328.2386

EMAIL

plksyj@vip.163.com